|
[1]TREPO C,CHAN HL,LOK A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063.
|
|
[2] LU FM,ZHUANG H.Management of hepatitis B in China[J].Chin Med J(Engl),2009,122(1):3-4.
|
|
[3]ALTER HJ.The unexpected outcomes of medical research:serendipity and the Australia antigen.Blumberg BS,Alter HJ,Visnich S.A new antigen in leukemia sera[J Am Med Assoc 1965,191:541-546][J].J Hepatol,2003,39(2):149-152.
|
|
[4]DUPINAY T,GHEIT T,ROQUES P,et al.Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island[J].Hepatology,2013,58(5):1610-1620.
|
|
[5]BARKER LF,MAYNARD JE,PURCELL RH,et al.Hepatitis B virus infection in chimpanzees:titration of subtypes[J].J Infect Dis,1975,132(4):451-458.
|
|
[6]WANG Q,SCHWARZENBERGER P,YANG F,et al.Experimental chronic hepatitis B infection of neonatal tree shrews(Tupaia belangeri chinensis):a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans[J].Virol J,2012,9:170.
|
|
[7]DANDRI M,LUTGEHETMANN M,PETERSEN J.Experimental models and therapeutic approaches for HBV[J].Semin Immunopathol,2013,35(1):7-21.
|
|
[8]CHISARI FV,PINKERT CA,MILICH DR,et al.A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J].Science,1985,230(4730):1157-1160.
|
|
[9]BABINET C,FARZA H,MORELLO D,et al.Specific expression of hepatitis B surface antigen(HBsA g)in transgenic mice[J].Science,1985,230(4730):1160-1163.
|
|
[10]GUIDOTTI L G,MATZKE B,SCHALLER H,et al.High-level hepatitis B virus replication in transgenic mice[J].J Virol,1995,69(10):6158-6169.
|
|
[11]WIELAND SF,SPANGENBERG HC,THIMME R,et al.Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees[J].Proc Natl Acad Sci U S A,2004,101(7):2129-2134.
|
|
[12]LARKIN J,CLAYTON M,SUN B,et al.Hepatitis B virus transgenic mouse model of chronic liver disease[J].Nat Med,1999,5(8):907-912.
|
|
[13]BARON JL,GARDINER L,NISHIMURA S,et al.Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection[J].Immunity,2002,16(4):583-594.
|
|
[14]PUBLICOVER J,GAGGAR A,NISHIMURA S,et al.Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B[J].J Clin Invest,2013,123(9):3728-3739.
|
|
[15]GOSSEN M,BUJARD H.Tight control of gene expression in mammalian cells by tetracycline-responsive promoters[J].Proc Natl Acad Sci U S A,1992,89(12):5547-5551.
|
|
[16]XU K,DENG XY,YUE Y,et al.Generation of the regulatory protein rtT A transgenic mice[J].World J Gastroenterol,2005,11(19):2885-2891.
|
|
[17]YU HM,LIU B,CHIU SY,et al.Development of a unique system for spatiotemporal and lineage-specific gene expression in mice[J].Proc Natl Acad Sci U S A,2005,102(24):8615-8620.
|
|
[18]LAN HY,ZHAO Y,YANG J,et al.Establishment of a novel triple-transgenic mouse:conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease[J].Mol Biol Rep,2014,41(11):7349-7359.
|
|
[19]YANG PL,ALTHAGE A,CHUNG J,et al.Hydrodynamic injection of viral DNA:a mouse model of acute hepatitis B virus infection[J].Proc Natl Acad Sci U S A,2002,99(21):13825-13830.
|
|
[20]TAKEHARA T,SUZUKI T,OHKAWA K,et al.Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication[J].J Hepatol,2006,44(2):267-274.
|
|
[21]HUANG LR,WU HL,CHEN PJ,et al.An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J].Proc Natl Acad Sci U S A,2006,103(47):17862-17867.
|
|
[22]HUANG YH,FANG CC,TSUNEYAMA K,et al.A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery[J].Int J Oncol,2011,39(6):1511-1519.
|
|
[23]ILAN E,BURAKOVA T,DAGAN S,et al.The hepatitis B virus-trimera mouse:a model for human HBV infection and evaluation of anti-HBV therapeutic agents[J].Hepatology,1999,29(2):553-562.
|
|
[24]OHASHI K,MARION PL,NAKAI H,et al.Sustained survival of human hepatocytes in mice:a model for in vivo infection with human hepatitis B and hepatitis delta viruses[J].Nat Med,2000,6(3):327-331.
|
|
[25]BROWN JJ,PARASHAR B,MOSHAGE H,et al.A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice[J].Hepatology,2000,31(1):173-181.
|
|
[26]BISSIG KD,WIELAND SF,TRAN P,et al.Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment[J].J Clin Invest,2010,120(3):924-930.
|
|
[27]DANDRI M,PETERSEN J.Chimeric mouse model of hepatitis B virus infection[J].J Hepatol,2012,56(2):493-495.
|
|
[28]DANDRI M,BURDA MR,TOROK E,et al.Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus[J].Hepatology,2001,33(4):981-988.
|
|
[29]RHIM JA,SANDGREN EP,PALMITER RD,et al.Complete reconstitution of mouse liver with xenogeneic hepatocytes[J].Proc Natl Acad Sci U S A,1995,92(11):4942-4946.
|
|
[30]PETERSEN J,DANDRI M,GUPTA S,et al.Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,1998,95(1):310-315.
|
|
[31]LUTGEHETMANN M,BORNSCHEUER T,VOLZ T,et al.Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice[J].Gastroenterology,2011,140(7):2074-2083.
|
|
[32]ZHOU XJ,SUN SH,WANG P,et al.Over-expression of uP A increases risk of liver injury in pA AV-HBV transfected mice[J].World J Gastroenterol,2012,18(16):1892-1902.
|
|
[33]AZUMA H,PAULK N,RANADE A,et al.Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il12rg-/-mice[J].Nat Biotechnol,2007,25(8):903-910.
|
|
[34]BILITY MT,ZHANG L,WASHBURN ML,et al.Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis[J].Nat Protoc,2012,7(9):1608-1617.
|
|
[35]WASHBURN ML,BILITY MT,ZHANG L,et al.A humanized mouse model to study hepatitis C virus infection,immune response,and liver disease[J].Gastroenterology,2011,140(4):1334-1344.
|
|
[36]BILITY MT,CHENG L,ZHANG Z,et al.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:induction of human-specific liver fibrosis and M2-like macrophages[J].PLoS Pathog,2014,10(3):e1004032.
|
|
[37]DEMBEK C,PROTZER U.Mouse models for therapeutic vaccination against hepatitis B virus[J].Med Microbiol Immunol,2015,204(1):95-102.
|
DownLoad: